Key facts
- This page summarizes Alexander J. Denner's Form 4 filing for Innoviva, Inc. (INVA).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 06 Mar 2025, 21:30.
Alexander J. Denner - 04 Mar 2025 Form 4 Insider Report for Innoviva, Inc. (INVA)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- INVA
- Reported as of
- 04 Mar 2025
- Net transaction value
- -$28,395,442
- SEC form
- 4
- Accepted by SEC
- 06 Mar 2025, 21:30:18 UTC
- Prior SEC filing
- 18 Dec 2024
- Next SEC filing
- 04 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- SARISSA CAPITAL MANAGEMENT LP; By: /s/ Mark DiPaolo, Senior Partner, General Counsel
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alexander J. Denner filed Form 4 for Innoviva, Inc. (INVA) on 06 Mar 2025.
Change
- Previous filing in this sequence was filed on 18 Dec 2024.
- Current net transaction value: -$28,395,442.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
This filing has been restated.
Open the amended filing.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INVA
transaction
Common Stock, par value $0.01 per share
Sale
- Transaction value
- $2,665,079
- Shares
- -151,175
- Change %
- -2.1%
- Price
- $17.63
- Shares after
- 7,125,825
- Date
- 04 Mar 2025
- Ownership
- See footnotes
- Footnotes
- F1, F4, F5
INVA
transaction
Common Stock, par value $0.01 per share
Sale
- Transaction value
- $4,766,126
- Shares
- -270,374
- Change %
- -3.8%
- Price
- $17.63
- Shares after
- 6,855,451
- Date
- 05 Mar 2025
- Ownership
- See footnotes
- Footnotes
- F2, F4, F5
INVA
transaction
Common Stock, par value $0.01 per share
Sale
- Transaction value
- $20,964,237
- Shares
- -1,196,746
- Change %
- -17%
- Price
- $17.52
- Shares after
- 5,658,705
- Date
- 06 Mar 2025
- Ownership
- See footnotes
- Footnotes
- F3, F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
On March 4, 2025, the Reporting Persons sold 151,175 shares of Common Stock at a weighted average price of $17.6291 per share. The shares were sold in multiple open market transactions at prices ranging from $17.55 to $17.89 per share, inclusive. The Reporting Persons undertake to provide, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
Footnote F2
On March 5, 2025, the Reporting Persons sold 270,374 shares of Common Stock at a weighted average price of $17.6279 per share. The shares were sold in multiple open market transactions at prices ranging from $17.49 to $17.72 per share, inclusive. The Reporting Persons undertake to provide, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
Footnote F3
On March 6, 2025, the Reporting Persons sold 1,196,746 shares of Common Stock at a weighted average price of $17.5177 per share. The shares were sold in multiple open market transactions at prices ranging from $17.48 to $17.64 per share, inclusive. The Reporting Persons undertake to provide, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
Footnote F4
Sarissa Capital Management LP ("Sarissa Capital") is the investment advisor to Sarissa Capital Offshore Master Fund LP, Sarissa Capital Catapult Fund LLC, Sarissa Capital Hawkeye Fund LP and Sarissa Capital Master Fund II LP (collectively, the "Sarissa Funds") and may be deemed to beneficially own the shares of Common Stock directly beneficially owned by the Sarissa Funds by virtue of the authority granted to it to vote and to dispose of the securities held by them, including the shares of Common Stock. Alexander J. Denner, Ph.D., a citizen of the United States of America ("Dr. Denner"), is the Chief Investment Officer and ultimate general partner of Sarissa Capital and is the ultimate general partner, or controls the managing member, of each of the Sarissa Funds; accordingly, Dr. Denner may be deemed to beneficially own the shares of Common Stock directly held by the Sarissa Funds by virtue of such positions.
Footnote F5
Each of Dr. Denner, Sarissa Capital and each of the Sarissa Funds disclaims beneficial ownership of the shares of Common Stock reported herein except, in each case, to the extent of their pecuniary interest therein.